Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extension

Benutzer: Gast

Titel:: Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extension
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Kim, Ho Jin; Nakashima, Ichiro; Viswanathan, Shanthi; Wang, Kai-Chen; Shang, Shulian; Miller, Larisa; Yountz, Marcus; Wingerchuk, Dean M.; Pittock, Sean J.; Levy, Michael; Berthele, Achim; Totolyan, Natalia; Palace, Jacqueline; Barnett, Michael H.; Fujihara, Kazuo
Zeitschriftentitel:: Multiple Sclerosis and Related Disorders
Jahr:: 2021
Band / Volume:: 50
Seitenangaben Beitrag:: 102849
Volltext / DOI:: doi:10.1016/j.msard.2021.102849
Verlag / Institution:: Elsevier BV
E-ISSN:: 2211-0348
Publikationsdatum:: 01.05.2021
BibTeX

Vorkommen: